Search Results - "MAYUMI, Tadanori"

Refine Results
  1. 1
  2. 2
  3. 3

    The use of PVP as a polymeric carrier to improve the plasma half-life of drugs by Kaneda, Yoshihisa, Tsutsumi, Yasuo, Yoshioka, Yasuo, Kamada, Haruhiko, Yamamoto, Yoko, Kodaira, Hiroshi, Tsunoda, Shin-ichi, Okamoto, Takayuki, Mukai, Yohei, Shibata, Hiroko, Nakagawa, Shinsaku, Mayumi, Tadanori

    Published in Biomaterials (01-07-2004)
    “…To achieve an optimum drug delivery such as targeting or controlled release utilizing bioconjugation with polymeric modifier, the conjugate between drugs and…”
    Get full text
    Journal Article
  4. 4

    Synthesis of a poly(vinylpyrrolidone-co -dimethyl maleic anhydride) co-polymer and its application for renal drug targeting by Tsutsumi, Yasuo, Kamada, Haruhiko, Sato-Kamada, Keiko, Yamamoto, Yoko, Yoshioka, Yasuo, Okamoto, Takayuki, Nakagawa, Shinsaku, Nagata, Satoshi, Mayumi, Tadanori

    Published in Nature biotechnology (01-04-2003)
    “…We have synthesized a polymeric drug carrier, polyvinylpyrrolidone-co-dimethyl maleic anhydride [poly(VP-co-DMMAn)], for use in renal drug delivery. About 80%…”
    Get full text
    Journal Article
  5. 5

    Tryprostatin A, a specific and novel inhibitor of microtubule assembly by Usui, T, Kondoh, M, Cui, C B, Mayumi, T, Osada, H

    Published in Biochemical journal (01-08-1998)
    “…We have investigated the cell cycle inhibition mechanism and primary target of tryprostatin A (TPS-A) purified from Aspergillus fumigatus. TPS-A inhibited cell…”
    Get full text
    Journal Article
  6. 6

    Optimization of transcriptional regulatory elements for constructing plasmid vectors by Xu, Z L, Mizuguchi, H, Ishii-Watabe, A, Uchida, E, Mayumi, T, Hayakawa, T

    Published in Gene (11-07-2001)
    “…In studies regarding both gene therapy and gene function, transgene expression by plasmid vectors benefits from the use of transcriptional regulatory elements…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development by Kunisawa, Jun, Nakagawa, Shinsaku, Mayumi, Tadanori

    Published in Advanced drug delivery reviews (19-11-2001)
    “…We prepared fusogenic liposomes by fusing conventional liposomes with an ultra-violet inactivated Sendai virus. Fusogenic liposomes can deliver encapsulated…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    The targeting of anionized polyvinylpyrrolidone to the renal system by Kodaira, Hiroshi, Tsutsumi, Yasuo, Yoshioka, Yasuo, Kamada, Haruhiko, Kaneda, Yoshihisa, Yamamoto, Yoko, Tsunoda, Shin-ichi, Okamoto, Takayuki, Mukai, Yohei, Shibata, Hiroko, Nakagawa, Shinsaku, Mayumi, Tadanori

    Published in Biomaterials (01-08-2004)
    “…We reported that the co-polymer composed of vinylpyrrolidone and maleic acid selectively distributed into the kidneys after i.v. injection. To further optimize…”
    Get full text
    Journal Article
  14. 14

    A strategy for efficient cross-presentation of CTL-epitope peptides leading to enhanced induction of in vivo tumor immunity by Hayashi, Akira, Wakita, Hisashi, Yoshikawa, Tomoaki, Nakanishi, Tsuyoshi, Tsutsumi, Yasuo, Mayumi, Tadanori, Mukai, Yohei, Yoshioka, Yasuo, Okada, Naoki, Nakagawa, Shinsaku

    Published in Journal of controlled release (22-01-2007)
    “…The activation of antitumor cytotoxic T-lymphocytes (CTLs) depends on how efficiently the relevant tumor antigen peptides are delivered into the major…”
    Get full text
    Journal Article
  15. 15

    Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins by NAKANISHI, T, KUNISAWA, J, HAYASHI, A, TSUTSUMI, Y, KUBO, K, NAKAGAWA, S, NAKANISHI, M, TANAKA, K, MAYUMI, T

    Published in Journal of controlled release (27-08-1999)
    “…In order to design an optimized liposome immunoadjuvant for inducing cell-mediated immune response against soluble proteinaceous antigens, we investigated the…”
    Get full text
    Journal Article
  16. 16

    Design of a pH-Sensitive Polymeric Carrier for Drug Release and Its Application in Cancer Therapy by KAMADA, Haruhiko, TSUTSUMI, Yasuo, MAYUMI, Tadanori, YOSHIOKA, Yasuo, YAMAMOTO, Yoko, KODAIRA, Hiroshi, TSUNODA, Shin-Ichi, OKAMOTO, Takayuki, MUKAI, Yohei, SHIBATA, Hiroko, NAKAGAWA, Shinsaku

    Published in Clinical cancer research (01-04-2004)
    “…Purpose: In this study, to optimize the polymeric drug delivery system for cancer chemotherapy, we developed a new pH-sensitive polymeric carrier,…”
    Get full text
    Journal Article
  17. 17

    Tight positive regulation of transgene expression by a single adenovirus vector containing the rtTA and tTS expression cassettes in separate genome regions by Mizuguchi, Hiroyuki, Xu, Zhi-Li, Sakurai, Fuminori, Mayumi, Tadanori, Hayakawa, Takao

    Published in Human gene therapy (01-09-2003)
    “…We previously developed single adenovirus (Ad) vectors that contained the components for a tetracycline-regulatable gene-expression system in the E1 and E3…”
    Get more information
    Journal Article
  18. 18

    Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12 by Okada, Naoki, Iiyama, Sayaka, Okada, Yuka, Mizuguchi, Hiroyuki, Hayakawa, Takao, Nakagawa, Shinsaku, Mayumi, Tadanori, Fujita, Takuya, Yamamoto, Akira

    Published in Cancer gene therapy (01-01-2005)
    “…Interleukin (IL)-12 is a key factor for inducing cellular immune responses, which play a central role in the eradication of cancer. In the present study, in…”
    Get full text
    Journal Article
  19. 19

    Vaccine Efficacy of Fusogenic Liposomes Containing Tumor Cell-Lysate against Murine B16BL6 Melanoma by Yoshikawa, Tomoaki, Okada, Naoki, Tsujino, Masaki, Gao, Jian-Qing, Hayashi, Akira, Tsutsumi, Yasuo, Mayumi, Tadanori, Yamamoto, Akira, Nakagawa, Shinsaku

    “…Recent advances in tumor immunology have facilitated the development of cancer immunotherapy targeting tumor-associated antigens (TAAs). However, because TAAs…”
    Get full text
    Journal Article
  20. 20